The global market for Swine Live Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Swine Live Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Swine Live Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Swine Live Vaccine include Boehringer Ingelheim, Harbin Pharmaceutical Group Bio-vaccine, DHN, Shenzhen BIOCBD Biotechnology, Jinyu Biotechnology, Zhongmu Industry, Qindao Lijian Bio-Tech, Wuhan Keqian Biology, Ceva Corporate, KM Biologics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Swine Live Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Live Vaccine.

The Swine Live Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Swine Live Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Swine Live Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Swine Live Vaccine Market Report

Report Metric	Details
Report Name	Swine Live Vaccine Market
Segment by Type	Porcine Reproductive and Respiratory Syndrome Vaccine Swine Fever Vaccine Pseudorabies Vaccine Others
Segment by Application	Breeding Farm Veterinary Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Boehringer Ingelheim, Harbin Pharmaceutical Group Bio-vaccine, DHN, Shenzhen BIOCBD Biotechnology, Jinyu Biotechnology, Zhongmu Industry, Qindao Lijian Bio-Tech, Wuhan Keqian Biology, Ceva Corporate, KM Biologics, Nisseiken
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Live Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Live Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Swine Live Vaccine Market report?

Ans: The main players in the Swine Live Vaccine Market are Boehringer Ingelheim, Harbin Pharmaceutical Group Bio-vaccine, DHN, Shenzhen BIOCBD Biotechnology, Jinyu Biotechnology, Zhongmu Industry, Qindao Lijian Bio-Tech, Wuhan Keqian Biology, Ceva Corporate, KM Biologics, Nisseiken

What are the Application segmentation covered in the Swine Live Vaccine Market report?

Ans: The Applications covered in the Swine Live Vaccine Market report are Breeding Farm, Veterinary Clinic

What are the Type segmentation covered in the Swine Live Vaccine Market report?

Ans: The Types covered in the Swine Live Vaccine Market report are Porcine Reproductive and Respiratory Syndrome Vaccine, Swine Fever Vaccine, Pseudorabies Vaccine, Others

1 Swine Live Vaccine Market Overview

1.1 Product Definition

1.2 Swine Live Vaccine by Type

1.2.1 Global Swine Live Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Porcine Reproductive and Respiratory Syndrome Vaccine

1.2.3 Swine Fever Vaccine

1.2.4 Pseudorabies Vaccine

1.2.5 Others

1.3 Swine Live Vaccine by Application

1.3.1 Global Swine Live Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Breeding Farm

1.3.3 Veterinary Clinic

1.4 Global Swine Live Vaccine Market Size Estimates and Forecasts

1.4.1 Global Swine Live Vaccine Revenue 2020-2031

1.4.2 Global Swine Live Vaccine Sales 2020-2031

1.4.3 Global Swine Live Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Swine Live Vaccine Market Competition by Manufacturers

2.1 Global Swine Live Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Swine Live Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Swine Live Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Swine Live Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Swine Live Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Swine Live Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Swine Live Vaccine, Date of Enter into This Industry

2.8 Global Swine Live Vaccine Market Competitive Situation and Trends

2.8.1 Global Swine Live Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Swine Live Vaccine Players Market Share by Revenue

2.8.3 Global Swine Live Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Swine Live Vaccine Market Scenario by Region

3.1 Global Swine Live Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Swine Live Vaccine Sales by Region: 2020-2031

3.2.1 Global Swine Live Vaccine Sales by Region: 2020-2025

3.2.2 Global Swine Live Vaccine Sales by Region: 2026-2031

3.3 Global Swine Live Vaccine Revenue by Region: 2020-2031

3.3.1 Global Swine Live Vaccine Revenue by Region: 2020-2025

3.3.2 Global Swine Live Vaccine Revenue by Region: 2026-2031

3.4 North America Swine Live Vaccine Market Facts & Figures by Country

3.4.1 North America Swine Live Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Swine Live Vaccine Sales by Country (2020-2031)

3.4.3 North America Swine Live Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Swine Live Vaccine Market Facts & Figures by Country

3.5.1 Europe Swine Live Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Swine Live Vaccine Sales by Country (2020-2031)

3.5.3 Europe Swine Live Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Swine Live Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Swine Live Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Swine Live Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Swine Live Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Swine Live Vaccine Market Facts & Figures by Country

3.7.1 Latin America Swine Live Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Swine Live Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Swine Live Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Swine Live Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Swine Live Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Swine Live Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Swine Live Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Swine Live Vaccine Sales by Type (2020-2031)

4.1.1 Global Swine Live Vaccine Sales by Type (2020-2025)

4.1.2 Global Swine Live Vaccine Sales by Type (2026-2031)

4.1.3 Global Swine Live Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Swine Live Vaccine Revenue by Type (2020-2031)

4.2.1 Global Swine Live Vaccine Revenue by Type (2020-2025)

4.2.2 Global Swine Live Vaccine Revenue by Type (2026-2031)

4.2.3 Global Swine Live Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Swine Live Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Swine Live Vaccine Sales by Application (2020-2031)

5.1.1 Global Swine Live Vaccine Sales by Application (2020-2025)

5.1.2 Global Swine Live Vaccine Sales by Application (2026-2031)

5.1.3 Global Swine Live Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Swine Live Vaccine Revenue by Application (2020-2031)

5.2.1 Global Swine Live Vaccine Revenue by Application (2020-2025)

5.2.2 Global Swine Live Vaccine Revenue by Application (2026-2031)

5.2.3 Global Swine Live Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Swine Live Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Boehringer Ingelheim

6.1.1 Boehringer Ingelheim Company Information

6.1.2 Boehringer Ingelheim Description and Business Overview

6.1.3 Boehringer Ingelheim Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Boehringer Ingelheim Swine Live Vaccine Product Portfolio

6.1.5 Boehringer Ingelheim Recent Developments/Updates

6.2 Harbin Pharmaceutical Group Bio-vaccine

6.2.1 Harbin Pharmaceutical Group Bio-vaccine Company Information

6.2.2 Harbin Pharmaceutical Group Bio-vaccine Description and Business Overview

6.2.3 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Portfolio

6.2.5 Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates

6.3 DHN

6.3.1 DHN Company Information

6.3.2 DHN Description and Business Overview

6.3.3 DHN Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 DHN Swine Live Vaccine Product Portfolio

6.3.5 DHN Recent Developments/Updates

6.4 Shenzhen BIOCBD Biotechnology

6.4.1 Shenzhen BIOCBD Biotechnology Company Information

6.4.2 Shenzhen BIOCBD Biotechnology Description and Business Overview

6.4.3 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Portfolio

6.4.5 Shenzhen BIOCBD Biotechnology Recent Developments/Updates

6.5 Jinyu Biotechnology

6.5.1 Jinyu Biotechnology Company Information

6.5.2 Jinyu Biotechnology Description and Business Overview

6.5.3 Jinyu Biotechnology Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Jinyu Biotechnology Swine Live Vaccine Product Portfolio

6.5.5 Jinyu Biotechnology Recent Developments/Updates

6.6 Zhongmu Industry

6.6.1 Zhongmu Industry Company Information

6.6.2 Zhongmu Industry Description and Business Overview

6.6.3 Zhongmu Industry Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Zhongmu Industry Swine Live Vaccine Product Portfolio

6.6.5 Zhongmu Industry Recent Developments/Updates

6.7 Qindao Lijian Bio-Tech

6.7.1 Qindao Lijian Bio-Tech Company Information

6.7.2 Qindao Lijian Bio-Tech Description and Business Overview

6.7.3 Qindao Lijian Bio-Tech Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Qindao Lijian Bio-Tech Swine Live Vaccine Product Portfolio

6.7.5 Qindao Lijian Bio-Tech Recent Developments/Updates

6.8 Wuhan Keqian Biology

6.8.1 Wuhan Keqian Biology Company Information

6.8.2 Wuhan Keqian Biology Description and Business Overview

6.8.3 Wuhan Keqian Biology Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Wuhan Keqian Biology Swine Live Vaccine Product Portfolio

6.8.5 Wuhan Keqian Biology Recent Developments/Updates

6.9 Ceva Corporate

6.9.1 Ceva Corporate Company Information

6.9.2 Ceva Corporate Description and Business Overview

6.9.3 Ceva Corporate Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Ceva Corporate Swine Live Vaccine Product Portfolio

6.9.5 Ceva Corporate Recent Developments/Updates

6.10 KM Biologics

6.10.1 KM Biologics Company Information

6.10.2 KM Biologics Description and Business Overview

6.10.3 KM Biologics Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.10.4 KM Biologics Swine Live Vaccine Product Portfolio

6.10.5 KM Biologics Recent Developments/Updates

6.11 Nisseiken

6.11.1 Nisseiken Company Information

6.11.2 Nisseiken Description and Business Overview

6.11.3 Nisseiken Swine Live Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Nisseiken Swine Live Vaccine Product Portfolio

6.11.5 Nisseiken Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Swine Live Vaccine Industry Chain Analysis

7.2 Swine Live Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Swine Live Vaccine Production Mode & Process Analysis

7.4 Swine Live Vaccine Sales and Marketing

7.4.1 Swine Live Vaccine Sales Channels

7.4.2 Swine Live Vaccine Distributors

7.5 Swine Live Vaccine Customer Analysis

8 Swine Live Vaccine Market Dynamics

8.1 Swine Live Vaccine Industry Trends

8.2 Swine Live Vaccine Market Drivers

8.3 Swine Live Vaccine Market Challenges

8.4 Swine Live Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim

Harbin Pharmaceutical Group Bio-vaccine

DHN

Shenzhen BIOCBD Biotechnology

Jinyu Biotechnology

Zhongmu Industry

Qindao Lijian Bio-Tech

List of Tables

Table 1. Global Swine Live Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Swine Live Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Swine Live Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Swine Live Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Swine Live Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Swine Live Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Swine Live Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Swine Live Vaccine Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Swine Live Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Swine Live Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Swine Live Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Swine Live Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Swine Live Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Live Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Swine Live Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Swine Live Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global Swine Live Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Swine Live Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global Swine Live Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Swine Live Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Swine Live Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Swine Live Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Swine Live Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Swine Live Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Swine Live Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America Swine Live Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America Swine Live Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Swine Live Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Swine Live Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Swine Live Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe Swine Live Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe Swine Live Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Swine Live Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Swine Live Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Swine Live Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Swine Live Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Swine Live Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Swine Live Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Swine Live Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Swine Live Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Swine Live Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Swine Live Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Swine Live Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Swine Live Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Swine Live Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Swine Live Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Swine Live Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Swine Live Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Swine Live Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global Swine Live Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global Swine Live Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Swine Live Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Swine Live Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Swine Live Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Swine Live Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Swine Live Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Swine Live Vaccine Price (USD/Unit) by Type (2020-2025)

Table 59. Global Swine Live Vaccine Price (USD/Unit) by Type (2026-2031)

Table 60. Global Swine Live Vaccine Sales (K Units) by Application (2020-2025)

Table 61. Global Swine Live Vaccine Sales (K Units) by Application (2026-2031)

Table 62. Global Swine Live Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Swine Live Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Swine Live Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Swine Live Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Swine Live Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Swine Live Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Swine Live Vaccine Price (USD/Unit) by Application (2020-2025)

Table 69. Global Swine Live Vaccine Price (USD/Unit) by Application (2026-2031)

Table 70. Boehringer Ingelheim Company Information

Table 71. Boehringer Ingelheim Description and Business Overview

Table 72. Boehringer Ingelheim Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Boehringer Ingelheim Swine Live Vaccine Product

Table 74. Boehringer Ingelheim Recent Developments/Updates

Table 75. Harbin Pharmaceutical Group Bio-vaccine Company Information

Table 76. Harbin Pharmaceutical Group Bio-vaccine Description and Business Overview

Table 77. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product

Table 79. Harbin Pharmaceutical Group Bio-vaccine Recent Developments/Updates

Table 80. DHN Company Information

Table 81. DHN Description and Business Overview

Table 82. DHN Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. DHN Swine Live Vaccine Product

Table 84. DHN Recent Developments/Updates

Table 85. Shenzhen BIOCBD Biotechnology Company Information

Table 86. Shenzhen BIOCBD Biotechnology Description and Business Overview

Table 87. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product

Table 89. Shenzhen BIOCBD Biotechnology Recent Developments/Updates

Table 90. Jinyu Biotechnology Company Information

Table 91. Jinyu Biotechnology Description and Business Overview

Table 92. Jinyu Biotechnology Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Jinyu Biotechnology Swine Live Vaccine Product

Table 94. Jinyu Biotechnology Recent Developments/Updates

Table 95. Zhongmu Industry Company Information

Table 96. Zhongmu Industry Description and Business Overview

Table 97. Zhongmu Industry Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Zhongmu Industry Swine Live Vaccine Product

Table 99. Zhongmu Industry Recent Developments/Updates

Table 100. Qindao Lijian Bio-Tech Company Information

Table 101. Qindao Lijian Bio-Tech Description and Business Overview

Table 102. Qindao Lijian Bio-Tech Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Qindao Lijian Bio-Tech Swine Live Vaccine Product

Table 104. Qindao Lijian Bio-Tech Recent Developments/Updates

Table 105. Wuhan Keqian Biology Company Information

Table 106. Wuhan Keqian Biology Description and Business Overview

Table 107. Wuhan Keqian Biology Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Wuhan Keqian Biology Swine Live Vaccine Product

Table 109. Wuhan Keqian Biology Recent Developments/Updates

Table 110. Ceva Corporate Company Information

Table 111. Ceva Corporate Description and Business Overview

Table 112. Ceva Corporate Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Ceva Corporate Swine Live Vaccine Product

Table 114. Ceva Corporate Recent Developments/Updates

Table 115. KM Biologics Company Information

Table 116. KM Biologics Description and Business Overview

Table 117. KM Biologics Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. KM Biologics Swine Live Vaccine Product

Table 119. KM Biologics Recent Developments/Updates

Table 120. Nisseiken Company Information

Table 121. Nisseiken Description and Business Overview

Table 122. Nisseiken Swine Live Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Nisseiken Swine Live Vaccine Product

Table 124. Nisseiken Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Swine Live Vaccine Distributors List

Table 128. Swine Live Vaccine Customers List

Table 129. Swine Live Vaccine Market Trends

Table 130. Swine Live Vaccine Market Drivers

Table 131. Swine Live Vaccine Market Challenges

Table 132. Swine Live Vaccine Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Swine Live Vaccine

Figure 2. Global Swine Live Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Swine Live Vaccine Market Share by Type: 2024 & 2031

Figure 4. Porcine Reproductive and Respiratory Syndrome Vaccine Product Picture

Figure 5. Swine Fever Vaccine Product Picture

Figure 6. Pseudorabies Vaccine Product Picture

Figure 7. Others Product Picture

Figure 8. Global Swine Live Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Swine Live Vaccine Market Share by Application: 2024 & 2031

Figure 10. Breeding Farm

Figure 11. Veterinary Clinic

Figure 12. Global Swine Live Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Swine Live Vaccine Market Size (2020-2031) & (US$ Million)

Figure 14. Global Swine Live Vaccine Sales (2020-2031) & (K Units)

Figure 15. Global Swine Live Vaccine Average Price (USD/Unit) & (2020-2031)

Figure 16. Swine Live Vaccine Report Years Considered

Figure 17. Swine Live Vaccine Sales Share by Manufacturers in 2024

Figure 18. Global Swine Live Vaccine Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Swine Live Vaccine Players: Market Share by Revenue in Swine Live Vaccine in 2024

Figure 20. Swine Live Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Swine Live Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Swine Live Vaccine Sales Market Share by Country (2020-2031)

Figure 23. North America Swine Live Vaccine Revenue Market Share by Country (2020-2031)

Figure 24. United States Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Swine Live Vaccine Sales Market Share by Country (2020-2031)

Figure 27. Europe Swine Live Vaccine Revenue Market Share by Country (2020-2031)

Figure 28. Germany Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Swine Live Vaccine Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Swine Live Vaccine Revenue Market Share by Region (2020-2031)

Figure 35. China Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Swine Live Vaccine Sales Market Share by Country (2020-2031)

Figure 45. Latin America Swine Live Vaccine Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Swine Live Vaccine Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Swine Live Vaccine Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Swine Live Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Swine Live Vaccine by Type (2020-2031)

Figure 55. Global Revenue Market Share of Swine Live Vaccine by Type (2020-2031)

Figure 56. Global Swine Live Vaccine Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Swine Live Vaccine by Application (2020-2031)

Figure 58. Global Revenue Market Share of Swine Live Vaccine by Application (2020-2031)

Figure 59. Global Swine Live Vaccine Price (USD/Unit) by Application (2020-2031)

Figure 60. Swine Live Vaccine Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions